Importance of the degree of antigen polymerization by detoxification in modulating the immunogenicity of acellular pertussis vaccine

Biotechnology and Bioprocess Engineering

Volumn 10, Issue 3, 2005, Pages 230-235

  Bae, Cheon Soon ^a   Hong, Sung Sang ^a   Ahn, Sang Jeom ^a   Jang, Yang Suk ^a   Hur, Byung Ki ^b  

^a Green Cross Company   (South Korea)

^b Inha University   (South Korea)

Author keywords

Acellular pertussis vaccine; Detoxification; Immunogenicity; Pertussis toxin; Polymerization degree

Indexed keywords

AGGLUTININ; BACTERIAL ANTIGEN; FORMALDEHYDE; LYSINE; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TOXOID;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG POTENCY; IMMUNOGENICITY; IMMUNOMODULATION; POLYMERIZATION;

EID: 21644452887     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02932018     Document Type: Article

References (22)

1. Global programme on vaccines (1996) State of the World's Vaccines and Immunization. World Health Organization, Geneva.
2. Edwards, K. M., M. D. Decker, and E. A. Mortimer Jr. (1999) Pertussis vaccine. pp. 293-344. In: S. A. Plotkin and W. A. Orenstein (eds.). Vaccines. W. B. Saunders company, Philadelphia, USA.
3. Yasuo, M. and T. Atsuko (1996) Pertussis vaccine. pp. 39-51. In: O. Akira (ed.). Vaccine Handbook. Maruzen Publisher, Tokyo, Japan.
4. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16: 1901-1906.
5. Hewlett, E. L. and S. A. Halperin (1998) Serological correlates of immunity to Bordetella pertussis. Vaccine 16: 1899-1900.
6. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16: 1907-1916.
7. Huet, M. E., E. Relyveld, and S. Camps (1992) Simplified activity evaluation of several tetanus vaccines. Biologicals 20: 35-43.
8. Relyveld, E. H., B. Bizzini, and R. K. Gupta (1998) Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 16: 1016-1023.
9. Seiji, S. O., O. S. Tamotsu, K. Satoru, and M. Tyoku (1984) Effect of pH and lysine during detoxification of a hemorrhagic principle of HABU snake venom (Trimeresurus, Flavoviridis) with formalin on the immunogenicity of the toxoid. Japan J. Med. Sci. Biol. 37: 225-231.
10. Guan, Y. X., H. X. Pan, Y. G. Gao, S. J. Yao, and M. G. Cho (2005) Refolding and purification of recombinant human interferon-γ expressed as inclusion bodies in Escherichia coli using size exclusion chromatography. Biotechnol. Bioprocess Eng. 10: 122-127.
11. Lim, I. H., K. J. Lee, E. K. Lee, M. R. Choi, G. W. Lee, Y. Yoon, D. H. Park, and K. H. Jung (2004) High-yield purification and characterization of recombinant human leukotactin-1 in Pichia pastoris. Biotechnol. Bioprocess Eng. 9: 1-6.
12. Bae, C. S., G. Y. Lim, J. S. Kim, and B. K. Hur (2003) Quadrivalent combined vaccine, including diphtheria toxoid, tetanus toxoid, detoxified whole cell pertussis, and hepatitis B surface antigen. J. Microbiol. Biotechnol. 13: 338-343.
13. Bae, C. S., K. N. Park, S. J. Ahn, J. S. Kim, and B. K. Hur (2002) Novel formulation of quadrivalent combined vaccine including diphtheria toxoid, tetanus toxoid, acellular pertussis antigens and hepatitis B surface antigen. J. Microbiol. Biotechnol. 12: 787-792.
14. Linggood, F. V., F. S. Muriel, A. J. Fulthorpe, A. J. Woiwod, and C. G. Pope (1962) The toxoiding of purified diphtheria toxin. Brit. J. exp. Path. 14: 177-188.
15. Scheibel, I. and C. P. Elo (1965) Irreversible detoxification of purified diphtheria toxin. Acta Pathol. Micrbiol. Scand. 65: 117-128.
16. Gupta, R. K., E. H. Relyveld, E. B. Lindbald, B. Bizzini, S. Benefraim, and C. K. Gupta (1993) Adjuvants: A balance between toxicity and adjuvanticity. Vaccine 11: 293-306.
17. Goldsby, R. A., T. J. Kindt, and B. A. Osborne (2000) Kuby Immunology. 4th ed., W. H. Freeman and Company, NY, USA.
18. Cooper, P. D. (1994) The selective induction of different immune responses by vaccine adjuvants. pp. 125-158. In: G. L. Ada (ed.). Strategies in Vaccine Design. Landes Company, Austin, USA.
19. Gupta, R. K. and B. E. Rost (2000) Aluminum compounds as vaccine adjuvants. pp. 73-74. In: D. T. O'Hagan (ed.). Vaccine Adjuvants: Preparation Methods and Research Protocols. Humana Press, New Jersey, USA.
20. Gupta, R. K. and G. R. Siber (1995) Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13: 1263-1276.
21. 3 as an immunological adjuvant. Acta Pathol. Microbiol. Immun. Scand. 96: 257-264.
22. Shirodkar, S., R. L. Hutchinson, D. L. Perry, J. L. White, and S. L. Hem (1990) Aluminum compounds used as adjuvants in vaccines. Pharm. Res. 7: 1282-1288.